A taxonomic schema of potential pitfalls in clinical variant analysis based on real-world evidence

被引:0
|
作者
Coovadia, Adam [1 ]
Boccuto, Luigi [1 ]
Chang, Yenui [1 ]
DeLuca, Jane [1 ]
机构
[1] Clemson Univ, Coll Behav Social & Hlth Sci, Clemson, SC 29634 USA
来源
PLOS ONE | 2023年 / 18卷 / 11期
关键词
QUALITATIVE CONTENT-ANALYSIS;
D O I
10.1371/journal.pone.0295010
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The classification and interpretation of genetic variants associated with genetic diseases have been shown to vary between clinical genetic laboratories. This can lead to errors introduced in the interpretation and public presentation of genetic findings in the literature and available databases. This qualitative study utilizes real-world evidence to introduce a taxonomic schema of potential pitfalls associated with public and commercial resources commonly used for sequence variant analysis. Databases, articles and other resources continue to evolve over time. A modified and expanded version of Reason's Model of Human Error with respect to variant analysis is proposed and discussed. This study complements professional standards and published recommendations of interpretive considerations associated with variant analysis and expands the scope of professional competency.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Potential pitfalls in the use of real-world data for studying long COVID
    Harrison G. Zhang
    Jacqueline P. Honerlaw
    Monika Maripuri
    Malarkodi Jebathilagam Samayamuthu
    Brendin R. Beaulieu-Jones
    Huma S. Baig
    Sehi L’Yi
    Yuk-Lam Ho
    Michele Morris
    Vidul Ayakulangara Panickan
    Xuan Wang
    Griffin M. Weber
    Katherine P. Liao
    Shyam Visweswaran
    Bryce W. Q. Tan
    William Yuan
    Nils Gehlenborg
    Sumitra Muralidhar
    Rachel B. Ramoni
    Isaac S. Kohane
    Zongqi Xia
    Kelly Cho
    Tianxi Cai
    Gabriel A. Brat
    [J]. Nature Medicine, 2023, 29 : 1040 - 1043
  • [2] Potential pitfalls in the use of real-world data for studying long COVID
    Zhang, Harrison G.
    Honerlaw, Jacqueline P.
    Maripuri, Monika
    Samayamuthu, Malarkodi Jebathilagam
    Beaulieu-Jones, Brendin R.
    Baig, Huma S.
    L'Yi, Sehi
    Ho, Yuk-Lam
    Morris, Michele
    Panickan, Vidul Ayakulangara
    Wang, Xuan
    Weber, Griffin M.
    Liao, Katherine P.
    Visweswaran, Shyam
    Tan, Bryce W. Q.
    Yuan, William
    Gehlenborg, Nils
    Muralidhar, Sumitra
    Ramoni, Rachel B.
    Kohane, Isaac S.
    Xia, Zongqi
    Cho, Kelly
    Cai, Tianxi
    Brat, Gabriel A.
    Aaron, James R.
    Agapito, Giuseppe
    Albayrak, Adem
    Albi, Giuseppe
    Alessiani, Mario
    Alloni, Anna
    Amendola, Danilo F.
    Angoulvant, Francois
    Anthony, Li L. L. J.
    Aronow, Bruce J.
    Ashraf, Fatima
    Atz, Andrew
    Avillach, Paul
    Azevedo, Paula S.
    Balshi, James
    Beaulieu-Jones, Brett K.
    Bell, Douglas S.
    Bellasi, Antonio
    Bellazzi, Riccardo
    Benoit, Vincent
    Beraghi, Michele
    Bernal-Sobrino, Jose Luis
    Bernaux, Melodie
    Bey, Romain
    Bhatnagar, Surbhi
    Blanco-Martinez, Alvar
    [J]. NATURE MEDICINE, 2023, 29 (05) : 1040 - 1043
  • [3] REAL-WORLD CLINICAL EVIDENCE DEVELOPMENT: AN ANALYSIS OF RELEVANT INTERNATIONAL MODELS FOR THE POTENTIAL IMPLEMENTATION OF SUCH A PROGRAM IN QUEBEC
    Bibeau, J.
    Savoie, M.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A17 - A18
  • [4] Clinical safety evaluation of contrast agents based on real-world evidence
    Jiang, Cheng
    Li, Junlian
    Huang, Yaoqin
    Huang, Daiying
    Lin, Jingran
    Jiang, Xin
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (06) : 1600 - 1605
  • [5] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [6] REAL-WORLD EVIDENCE ON THE RISE: EVALUATING THE USE OF REAL-WORLD EVIDENCE IN ICER ASSESSMENTS OF COMPARATIVE CLINICAL EFFECTIVENESS
    Drane, E.
    Upton, E.
    Morten, P.
    Walker, E.
    [J]. VALUE IN HEALTH, 2019, 22 : S316 - S316
  • [7] Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization
    Schaumberg, Debra
    Larholt, Kay
    Apgar, Elizabeth
    Pashos, Chris L.
    Hirsch, Gigi
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 472 - 475
  • [8] Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization
    Debra Schaumberg
    Kay Larholt
    Elizabeth Apgar
    Chris L. Pashos
    Gigi Hirsch
    [J]. Therapeutic Innovation & Regulatory Science, 2023, 57 : 472 - 475
  • [9] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [10] ANALYSIS OF REAL-WORLD EVIDENCE AND REAL-WORLD DATA BY CONITEC, BRAZILIAN HTA AGENCY
    Nita, M. E.
    Riveros, B. S.
    Vaz, P.
    Mussolino, F.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A286 - A286